Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold M Katz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Atherosclerosis. Supplements|May 23, 2006
Should trans fatty acids be viewed as membrane-active drugs?Arnold M Katz
Circulation. Heart Failure|October 8, 2009
The "modern" view of heart failure: how did we get here?Arnold M Katz
Journal of Molecular and Cellular Cardiology|March 28, 2006
Michiko Tada (1938-2005)Arnold M Katz
Circulation Journal : Official Journal of the Japanese Circulation Society|April 2, 2002
Proliferative signaling and disease progression in heart failureArnold M Katz
The Medical Clinics of North America|April 16, 2003
Pathophysiology of heart failure: identifying targets for pharmacotherapyArnold M Katz
Journal of Cardiac Failure|March 8, 2008
The "gap" between bench and bedside: widening or narrowing?Arnold M Katz
Circulation|February 13, 2002
Trans-fatty acids and sudden cardiac deathArnold M Katz
Cardiovascular Drugs and Therapy|October 11, 2002
Maladaptive growth in the failing heart: the cardiomyopathy of overloadArnold M Katz
The Physiologist|October 6, 2015
Impact FactorsArnold M Katz
Circulation|December 4, 2002
Ernest Henry Starling, his predecessors, and the "Law of the Heart"Arnold M Katz
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Atherosclerosis. Supplements|May 23, 2006
Should trans fatty acids be viewed as membrane-active drugs?Arnold M Katz
Circulation. Heart Failure|October 8, 2009
The "modern" view of heart failure: how did we get here?Arnold M Katz
Journal of Molecular and Cellular Cardiology|March 28, 2006
Michiko Tada (1938-2005)Arnold M Katz
Circulation Journal : Official Journal of the Japanese Circulation Society|April 2, 2002
Proliferative signaling and disease progression in heart failureArnold M Katz
The Medical Clinics of North America|April 16, 2003
Pathophysiology of heart failure: identifying targets for pharmacotherapyArnold M Katz
Journal of Cardiac Failure|March 8, 2008
The "gap" between bench and bedside: widening or narrowing?Arnold M Katz
Circulation|February 13, 2002
Trans-fatty acids and sudden cardiac deathArnold M Katz
Cardiovascular Drugs and Therapy|October 11, 2002
Maladaptive growth in the failing heart: the cardiomyopathy of overloadArnold M Katz
The Physiologist|October 6, 2015
Impact FactorsArnold M Katz
Circulation|December 4, 2002
Ernest Henry Starling, his predecessors, and the "Law of the Heart"Arnold M Katz
Pageof 2